North Carolina Patent of the Month – November 2023

Cutting Edge Spine, LLC (CES) has been a pioneering force in the medical device industry since its establishment in 2009, introducing groundbreaking spinal technologies that redefine surgical practices. With an ardent belief in delivering enhanced value to patients, payers, and healthcare providers, CES has been committed to developing and distributing state-of-the-art spinal implant systems that cater to both clinical and economic needs.

The company’s core focus lies in addressing critical orthopedic requirements, particularly concerning bone repair, stabilization, and correction. CES understands the complexity of spinal conditions, exemplified in the intricate needs of the sacroiliac joint—critical for spinal stability. To combat conditions like sacroiliac dysfunction or instability, CES sought to develop implant devices that not only secure bones but also maintain stability in the face of joint rotation or movement.

The EVOS-ha stands as a testament to their pioneering work, marked as the first Lumbar Interbody system in the United States designed with PEEK-OPTIMA Enhanced, a significant milestone in the spinal industry. This implant system is FDA cleared, highlighting CES’s dedication to introducing innovative and regulatory-approved technologies.

Sacroiliac dysfunction, often challenging to diagnose due to symptoms commonly linked with other orthopedic problems, demanded an innovative solution to secure and stabilize the sacroiliac joint more effectively. CES’s focus on developing devices to prevent rotational failures and enhance tissue integration showcases a forward-thinking approach to spinal implants.

Their endeavors in producing systems that not only provide secure bone fixation but also resist rotation and pull-out failures illustrate their commitment to improving joint stability and implant integration. CES’s mission has been to offer more advanced and reliable devices that overcome the limitations of traditional bone screw implants, thereby significantly improving spinal care and patient outcomes.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at or contact your usual Swanson Reed representative.

Recent Posts